Clinical Trials
GBT Announces Efficacy Data from All Patients Enrolled in Phase 3 Study Sustained Improvements in Hemoglobin with Voxelotor
GBT
PR-M06-19-NI-025Jun 18, 2019
Oncology
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO®
Eli Lilly and Company
PR-M01-19-NI-067Jan 23, 2019
PR-M10-18-NI-081
BiondVax Receives €8M From the European Investment Bank (EIB) in Support of Manufacturing Facility and Ongoing Phase 3 Clinical Trial
BiondVax
InvestmentOct 24, 2018
Phase III Trial
Takeda Announces Phase 3 Trial of ALUNBRIG® (brigatinib) Met Primary Endpoint Demonstrating Superiority in Progression-Free Survival Versus Crizotinib
Takeda
PR-M07-18-NI-094Jul 27, 2018
Phase III Trial
Endoscopy Publishes the Dayb Phase III Trial for Plenvu®(Ner1006), the First One Litre Peg Bowel Preparation[i]
Norgine
PR-M07-18-NI-089Jul 26, 2018
Clinical Data
Array BioPharma Announces a 62% Observed Overall Survival at One Year from the Phase 3 BEACON CRC Safety Lead-In
Array BioPharma
PR-M06-18-NI-086Jun 26, 2018
Clinical Trials
Sage Announces Pivotal Phase 3 Trial Status for SAGE-217 in Major Depressive Disorder and Postpartum Depression based on FDA Breakthrough Therapy Meeting
Sage Therapeutics
PR-M06-18-NI-060Jun 18, 2018
Clinical Data
Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant
Allergan, plc
PR-M06-18-NI-051Jun 14, 2018
Clinical Data
NWBio Announces Scientific Publication of Interim Survival Data From Phase 3 Trial of DCVax®-L for Glioblastoma Brain Cancer
Northwest Biotherapeutics
PR-M06-18-NI-009Jun 04, 2018
Trial Results
IMBRUVICA® (ibrutinib) Plus GAZYVA® (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint
AbbVie
PR-M05-18-NI-102May 28, 2018
Phase 3 Trial
LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint
Pfizer
PR-M05-18-NI-077May 21, 2018